Voloridge Investment Management’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$354K Buy
2024
Q4
Sell
2024
Q3
$442K Buy
2024
Q2
$272K Buy